Summary
Takahiro Yano is a life sciences founder and scientist-executive with 14+ years of experience translating biochemical and microbiological research into funded drug-discovery and diagnostic projects. As Co-Founder and CEO of Endless Biopolymers and former senior scientist/project leader at Vironika and RMH Sciences, he has led antiviral and antibiotic discovery programs, secured multiple NIH SBIR/STTR awards as PI, and shepherded candidates from hit ID to development. Trained as a PhD chemist, he combines deep mechanistic expertise in enzymology, protein chemistry and bioengineering with hands-on assay design, HTS, and novel diagnostic platform development. He excels at project planning, budgeting, and cross-disciplinary team leadership, having designed research facilities and run international collaborations across academia, national institutes, and industry. Less obvious is his track record of turning fundamental biophysics discoveries (e.g., complex I and ATP synthase work) into practical screening assays and patentable technologies that drive business outcomes. Based in Tokyo with a global footprint, he pairs rigorous academic pedigree with entrepreneurial grit to accelerate early-stage biotech programs.
14 years of coding experience
23 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Chemistry, Doctor of Philosophy (Ph.D.), Chemistry at Tokyo Institute of Technology
English, Japanese